Dear Members:
We are performing a proposal research to audit appropriate use of
Angiotensin-coverting enzyme inhibitors and thrombolytic therapy in
Coronary Heart Disease, in the main hospital in our city. To define
appropriate use of those drugs, weŽll use the WHO general definition of.
Does anyone know some research about this issue? May anyone suggests
possible criteria?
Many thanks anticipated
Arturo Marti-Carvajal
Universidad de Carabobo
Venezuela
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|